早期癌症检测公司艾米森闯港股:年入不足千万,关联交易撑起半边天

创业最前线
Oct 21

出品 | 创业最前线作者 | 张珏编辑 | 蛋总美编 | 邢静审核 | 颂文被誉为“中国癌症早筛第一股”的诺辉健康,如今正处在退市边缘。截至2025年9月27日,被证实财务造假的诺辉健康已在港交所停牌整整18个月,港交所《主板上市规则6.01A(1)》规定,上市企业连续停牌18个月后,港交所可以取消其上市地位。曾经的行业领跑者坠入深渊,也让整个癌症早筛赛道再次被打上问号。外界开始重新审视:这条被...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10